Avail Medsystems Raises $100 Million in Series B Funding Led by D1 Capital to Meet Demand for Procedural Telemedicine™ Technology for the Operating Room
Avail Medsystems Raises $100 Million in Series B Funding Led by D1 Capital to Meet Demand for Procedural Telemedicine™ Technology for the Operating Room
10/07/20, 2:49 PM
Location
palo altoMoney raised
$100 million
Round Type
series b
Avail Medsystems, the medical technology company pioneering telemedicine for the procedure room (“Procedural TelemedicineTM”), today announced that it has raised $100 million in Series B funding led by D1 Capital Partners, with participation from 8VC and existing investors. Avail previously raised $25 million in Series A and Series A-1 funding from investors including Lux Capital, Coatue, Sonder Capital, Playground Global, Baidu Ventures, and Refractor Capital.
Company Info
Company
Avail Medsystems
Location
palo alto, california, united states
Additional Info
Avail Medsystems is a pioneering medical technology company that removes the barriers of in-person medical procedure collaboration. With a customer-centric business model, Avail’s purpose-built Procedural TelemedicineTM technology digitizes physical presence and enables on-the-go, HIPAA compliant collaboration among a network of healthcare professionals and industry experts.